Скачать или смотреть Cisplatin resistance in testicular germ cell tumors with Dr. Lucia Kucerova

What you will learn in this 11-minute webinar:

About the challenges of cisplatin-resistant testicular germ cell tumors.
How novel therapeutic compounds and combination therapies are screened and evaluated for the treatment of cisplatin-resistant testicular germ cells.
How the Maestro Z impedance assay sensitively measures real-time cytotoxicity to quickly validate compounds identified by high-throughput screening.

For more information visit: https://bit.ly/4eGrzJd

Testicular germ cell tumors represent the most common malignancy in men between 20-40 years of age, and while cisplatin-based chemotherapy has been a highly effective therapeutic approach, about 5-15% of patients develop recurrent chemo-resistant malignancies.In this webinar, Dr. Lucia Kucerova (Comenius University Medical Faculty and Cancer Research Institute of Biomedical Research Center, Bratislava) discusses her translational research into novel combination treatments for cisplatin-resistant testicular germ cell tumors.